New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
07:36 EDTENZYEnzymotec sees FY14 EPS 64c-94c, consensus 86c
Sees FY14 revenue, based on the proportionate consolidation method, $90M-$110M, consensus $92.95M. Sees FY14 revenue, based on the equity method, $68M-$85M.
News For ENZY From The Last 14 Days
Check below for free stories on ENZY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 12, 2014
08:15 EDTENZYEnzymotec initiates clinical study on Autism Spectrum Disorder symptoms
Subscribe for More Information
August 6, 2014
10:00 EDTENZYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:56 EDTENZYEnzymotec price target lowered to $12 from $25 at Canaccord
Subscribe for More Information
06:30 EDTENZYEnzymotec downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use